W
Werner Hacke
Researcher at Heidelberg University
Publications - 688
Citations - 93115
Werner Hacke is an academic researcher from Heidelberg University. The author has contributed to research in topics: Stroke & Thrombolysis. The author has an hindex of 123, co-authored 656 publications receiving 84593 citations. Previous affiliations of Werner Hacke include University Hospital Heidelberg & Steklov Mathematical Institute.
Papers
More filters
Journal ArticleDOI
Antiplatelet Therapy After Noncardioembolic Stroke.
Jacoba P. Greving,Hans-Christoph Diener,Johannes B. Reitsma,Philip M.W. Bath,László Csiba,Werner Hacke,L. Jaap Kappelle,Peter J. Koudstaal,Didier Leys,Jean-Louis Mas,Ralph L. Sacco,Ale Algra,Ale Algra +12 more
TL;DR: In this article, the efficacy and safety of antiplatelet agents after noncardioembolic stroke or transient ischemic attack and examined how these vary according to patients' demographic and clinical characteristics.
Book ChapterDOI
General Therapy of Acute Ischemic Stroke
TL;DR: Today most stroke investigators agree that the optimal time window for treatment of patients with acute brain infarction is less than 8 h, perhaps less than 2 h in some cases, and enthusiasm for immediate treatment has developed during the past few years.
Journal ArticleDOI
Bootstrap statistics of ECASS II data: just another post hoc analysis of a negative stroke trial?
TL;DR: This post hoc analysis of ECASS II data was designed to make the least number of a priori assumptions by a bootstrap-based hypothesis test on a non-parametric test statistic and rejected the null hypothesis.
Journal ArticleDOI
Fast Point-of-Care Coagulometer Guided Reversal of Oral Anticoagulation at the Bedside Hastens Management of Acute Subdural Hemorrhage
Timolaos Rizos,Ekkehart Jenetzky,Christian Herweh,Andreas Unterberg,Werner Hacke,Roland Veltkamp +5 more
TL;DR: Using POC to measure INR values and patient-adapted PCC administration is a fast and economic method to reverse anticoagulation in patients with acute OAC-SDH.
Journal ArticleDOI
Alternative Calculations of Individual Patient Time in Therapeutic Range While Taking Warfarin: Results From the ROCKET AF Trial
Daniel E. Singer,Anne S. Hellkamp,Zhong Yuan,Yuliya Lokhnygina,Manesh R. Patel,Jonathan P. Piccini,Graeme J. Hankey,Günter Breithardt,Jonathan L. Halperin,Richard C. Becker,Werner Hacke,Christopher C. Nessel,Kenneth W. Mahaffey,Keith A.A. Fox,Robert M. Califf +14 more
TL;DR: TTR, the standard measure of control of warfarin anticoagulation, depends on imputing daily INR values for the vast majority of follow‐up days and the TTR calculation method may better reflect the impact ofwarfarin dose changes than the Rosendaal approach.